Most Popular Stories on StockNews.com Why Are Stocks Struggling with 4,000? The S&P 500 (SPY) has flirted with a series of moves up towards 4,000. Each time we fall short. And each time we either see a volatile pullback or nasty sector rotation. The latter seems to be more of what is happening at this time. So let’s dissect the action to plot our trading plan forward including insight on the top 10 stocks and 3 ETFs for today’s market environment. Read on… Mar 24, 2021 | 2:30pm 3 Stocks that Wall Street Thinks Will Double Wall Street is betting on the biotech industry. Many biopharma stocks are close to developing drugs for chronic and life-threatening ailments. With impressive clinical trial results and growth potential, we believe stocks such as Immunovant (IMVT), Zogenix (ZGNX), and Spectrum Pharmaceuticals (SPPI) might double in value in the near term. Let’s discuss.